Alternative RNA splicing in cancer: what about adult T-cell leukemia?
Eukaryotic cells employ a broad range of mechanisms to regulate gene expression. Among others, mRNA alternative splicing is a key process. It consists of introns removal from an immature mRNA (pre-mRNA) via a transesterification reaction to create a mature mRNA molecule. Large-scale genomic studies...
Main Authors: | Julie Tram, Jean-Michel Mesnard, Jean-Marie Peloponese |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.959382/full |
Similar Items
-
Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia
by: Peng Jin, et al.
Published: (2020-09-01) -
HTLV-1 bZIP factor: the key viral gene for pathogenesis
by: Masao Matsuoka, et al.
Published: (2020-01-01) -
Retroviral Antisense Transcripts and Genes: 33 Years after First Predicted, a Silent Retroviral Revolution?
by: Roger H. Miller, et al.
Published: (2021-11-01) -
Human T-Cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets
by: Francesca Marino-Merlo, et al.
Published: (2023-09-01) -
Hijacking of the AP-1 Signaling Pathway during Development of ATL
by: Hélène Gazon, et al.
Published: (2018-01-01)